Personal information

Verified email addresses

Spain

Biography

Doctor of Sciences, University of Navarra, 1992. Professor of Immunology of the University of Navarra and Researcher at the Centro de Investigacion Médica Aplicada (CIMA).
After obtaining the degree in Biological Sciences (University of Navarra in 1988), I joined the Department of Medicine at the University Clinic of Navarra where I completed my PhD (December 1992). After a postdoctoral period I was hired in 1995 as a researcher by the Instituto Científico y Tecnológico de Navarra (ICT) and became part of the staff of the Center for Applied Medical Research (CIMA) in 2002. I made stays at the Hospital Cochin and the Institute Pasteur in Paris. In 1995 I was hired as a professor by the University of Navarra where I received the appointment of Professor of Immunology in 2014 (Acreditted as Profesor Catedrático by ANECA in 2015)
My scientific activity has been focused on the Area of immunology and the development of antiviral and antitumor vaccines and immunotherapies. I worked on the characterization of mechanisms of induction of cellular and humoral immune responses, the study of the immune-escape mechanisms of viruses and tumors, as well as on the characterization and development of inhibitory molecules of different biological processes.
I have developed and patented vaccination methods, some of them have been transferred to the pharmaceutical industry. I have worked on the identification and characterization of inhibitory molecules against immunosuppressive molecules such as TGF-beta, IL-10 or the transcription factor FOXP3, which are now under development.
Since the beginning of my professional activity in 1989, I have participated in the publication of more than 150 articles in international journals, and in more than 100 communications to Congresses. I have directed 12 Doctoral Theses (five of them recognized with the extraordinary Doctorate Award, University of Navarra) and I have been co-inventor in 17 patents. . I have participated in more than 25 research projects funded by CYCIT, Carlos III Health Institute, European Union, Government of Navarra and private organizations, being principal investigator in 17 of them.

I currently serve as the Head of the Immunology and Immunotherapy program at CIMA.

Activities

Employment (1)

Centro de Investigación Médica Aplicada: Pamplona, Navarra, ES

2002-10-01 to present | Director (Programa de Inmunología e Inmunoterapia)
Employment
Source: Self-asserted source
Juan J Lasarte

Education and qualifications (1)

Universidad de Navarra: Pamplona, Navarra, ES

1988-01-08 to 1992-12-18 | Doctor en Biología celular (Medicina Interna)
Education
Source: Self-asserted source
Juan J Lasarte

Funding (20)

Accelerating Development and Improving Access to CAR and TCR engineered T cell therapy (T2EVOLVE)

2021 to 2025 | Grant
European Union H2020 (Brussels, BE)
GRANT_NUMBER:

H2020-JTI-IMI2-2019-18

Source: Self-asserted source
Juan J Lasarte

Targeting the tumor microenvironment to improve CAR-T cell based immunotherapy in pancreatic cancer

2021 to 2023 | Grant
Ministerio de Ciencia e Innovación (Madrid, ES)
GRANT_NUMBER:

PLEC2021-008094

Source: Self-asserted source
Juan J Lasarte

Targeting the tumor microenvironment to improve CAR-T cell based immunotherapy in pancreatic cancer

2021 to 2023 | Grant
Gobierno de España (Madrid, ES)
GRANT_NUMBER: PLEC2021-008094
Source: check_circle
CIÊNCIAVITAE

Desarrollo EStratégico de terapias CART para el tratamiento de Tumores Hematológicos y Sólidos (DESCARTHeS)

2019 to 2022 | Grant
Gobierno de Navarra (Pamplona, ES)
GRANT_NUMBER:

0011-1411-2019-000079

Source: Self-asserted source
Juan J Lasarte
grade
Preferred source (of 2)‎

Targeting the tumor microenvironment to improve CAR-T cell based immunotherapy in solid tumors.

2019 to 2022 | Grant
Ministerio de Ciencia e Innovación (Madrid, ES)
GRANT_NUMBER:

PID2019-108989RB-I00

Source: Self-asserted source
Juan J Lasarte
grade
Preferred source (of 2)‎

SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma, a rare hematologic disease (CARAMBA)

2018 to 2023 | Grant
European Union H2020 (Brussels, BE)
GRANT_NUMBER:

SC1-PM-08-2017

Source: Self-asserted source
Juan J Lasarte

Neuronal self-renewal by antigen-specific tolerization in multiple sclerosis reinstalling the balance between inflammation and regeneration

2018 to 2022 | Grant
European Union (Brussels, BE)
GRANT_NUMBER:

Grant Agreement number: 779316

Source: Self-asserted source
Juan J Lasarte
grade
Preferred source (of 2)‎

Plataformas automáticas de producción de células CAR T para el tratamiento de leucemia B y linfoma B (AUTOCART)

2018 to 2021 | Grant
Ministerio de Ciencia e Innovación (Madrid, ES)
GRANT_NUMBER:

RTC-2017-6578-1

Source: Self-asserted source
Juan J Lasarte
grade
Preferred source (of 2)‎

Dual epigenetic targeting and immunotherapy to fight against cancer.

2017 to 2019 | Grant
Instituto de Salud Carlos III (Madrid, ES)
GRANT_NUMBER:

AC16/00041

Source: Self-asserted source
Juan J Lasarte
grade
Preferred source (of 2)‎

Gene editing of key transcription factors to improve the antitumor efficacy of Adoptive T Cell Therapy

2017 to 2019 | Grant
Fundación Ramón Areces (Madrid, ES)
Source: Self-asserted source
Juan J Lasarte

Targeting the ion transporter machinery in hematologic malignancies and other cancers.

2015 to 2016 | Grant
Química Farmacéutica Bayer, (Madrid, ES)
GRANT_NUMBER:

2015-03-1233

Source: Self-asserted source
Juan J Lasarte

Desarrollo de una vacuna terapéutica frente al cáncer de cérvix basada en la proteína de fusión entre el dominio extra A de la fibronectina y el antígeno E7 del HPV.

2014 to 2017 | Grant
Ministerio de Economía y Competitividad (Madrid, ES)
GRANT_NUMBER:

RTC-2014-1615-1

Source: Self-asserted source
Juan J Lasarte

Estimulación del sistema nervioso central a través del sistema olfativo como método de potenciación de la respuesta inmune antitumoral y antiviral.

2014 to 2016 | Grant
Ministerio de Economía y Competitividad (Madrid, ES)
GRANT_NUMBER:

SAF2013-50067-EXP

Source: Self-asserted source
Juan J Lasarte

Red de inmunoterapia del cáncer.

2014 to 2016 | Grant
Ministerio de Ciencia y Tecnología (Madrid, ES)
GRANT_NUMBER:

SAF2014-53563

Source: Self-asserted source
Juan J Lasarte
grade
Preferred source (of 2)‎

HEPACUTE: Host and viral factors in acute hepatitis

2010 to 2014 | Grant
European Union (Brussels, BE)
GRANT_NUMBER:

260844

Source: Self-asserted source
Juan J Lasarte
grade
Preferred source (of 2)‎

Bloqueo de los mecanismos de inmunosupresión para aumentar la eficacia de la vacunación frente al cancer y enfermedades infecciosas crónicas

2010 to 2012 | Grant
Ministerio de Ciencia e Inmovación (madrid, ES)
GRANT_NUMBER:

SAF201015060

Source: Self-asserted source
Juan J Lasarte

Desarrollo de péptidos inhibidores de la acción de las células T reguladoras para el tratamiento del cáncer.

2007 to 2010 | Grant
Miniasterio de Ciencia e Innovación (Madrid, ES)
GRANT_NUMBER:

SAF2007-61432

Source: Self-asserted source
Juan J Lasarte

Development of an effective RNA interference-based anti-HIV-1 therapy using an SV40-derived gene transfer vector

2007 to 2010 | Grant
European Union (Brussels, BE)
GRANT_NUMBER:

HIVSTOP 037301

Source: Self-asserted source
Juan J Lasarte
grade
Preferred source (of 2)‎

Anticuerpos intracelulares frente a la proteína del core del virus de la hepatitis C (VHC) como estrategia para el tratamiento de la hepatitis crónica C

2003 to 2006 | Grant
Instituto de Salud Carlos III (Madrid, ES)
Source: Self-asserted source
Juan J Lasarte

Inducción preferencial de linfocitos TH1 o TH2 mediante péptidos sintéticos. Posible aplicación al tratamiento de infecciones crónicas y del hepatocarcinoma

1997 to 2000 | Grant
Comisión Interministerial de Ciencia y Tecnología (Madrid, ES)
GRANT_NUMBER:

SAF 97-0223

Source: Self-asserted source
Juan J Lasarte

Peer review (5 reviews for 4 publications/grants)

Review activity for Biochimica et biophysica acta CR. (1)
Review activity for Cancers. (2)
Review activity for Molecular and cellular biochemistry. (1)
Review activity for The Innovation. (1)